WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005063794) A PROCESS FOR THE PREPARATION AND PURIFICATION OF RECOMBINANT PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/063794    International Application No.:    PCT/IN2004/000257
Publication Date: 14.07.2005 International Filing Date: 23.08.2004
IPC:
C07K 1/36 (2006.01)
Applicants: BHARAT BIOTECH INTERNATIONAL LIMITED [IN/IN]; Genome Valley, Turkapally Shameerpet, Hyderabad 500 078 (IN) (For All Designated States Except US).
ELLA, Krishna, Murthy [IN/IN]; (IN) (For US Only).
VELLIMEDU, Srinivas, Kannappa [IN/IN]; (IN) (For US Only)
Inventors: ELLA, Krishna, Murthy; (IN).
VELLIMEDU, Srinivas, Kannappa; (IN)
Agent: BALASUBRAHMANYAM, Lakshmi; Corporate Law Group, 1106-1107 Kaikash Building, 26 K.G. Marg, New Delhi 110 001 (IN)
Priority Data:
1061/CHE/2003 30.12.2003 IN
Title (EN) A PROCESS FOR THE PREPARATION AND PURIFICATION OF RECOMBINANT PROTEINS
(FR) PROCEDE DE PREPARATION ET DE PURIFICATION DE PROTEINES DE RECOMBINAISON
Abstract: front page image
(EN)A novel process for the purification of recombinant protein expressed as protein or particle is herewith described. In this purification process, the protein is purified by hydrophobic interaction. The interaction of this protein step resulted in an increase in recovery and purity from 15%-80%. The protein further purified has its application in vaccines and pharmaceuticals.
(FR)L'invention porte sur un nouveau procédé de purification d'une protéine de recombinaison exprimée comme protéine ou particule. Dans ce procédé de purification, la protéine est purifiée par interaction hydrophobe. L'interaction de cette étape de purification de la protéine a entraîné une augmentation du taux de récupération et de pureté allant e 15 % à 80 %. La protéine purifiée peut avoir également une application dans les vaccins et les produits pharmaceutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)